Cargando…
Applicability of pan-TRK immunohistochemistry for identification of NTRK fusions in lung carcinoma
In the last two decades, various therapies have been introduced for lung carcinoma patients, including tyrosine-kinase inhibitors for different mutations. While some of them are specific to specific tumor types, others, like NTRK1–3 fusions, are found in various solid tumors. The occurrence of an NT...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105314/ https://www.ncbi.nlm.nih.gov/pubmed/33963267 http://dx.doi.org/10.1038/s41598-021-89373-3 |